Oncotelic Therapeutics Inc
(OTLC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,440 | -11,490 | N/A | -5,958 | -3,718 |
| Depreciation Amortization | 50 | 60 | N/A | 37 | 14 |
| Other Working Capital | -1,970 | 1,620 | N/A | -99 | 131 |
| Other Operating Activity | 1,050 | 1,260 | 0 | 1,047 | 254 |
| Operating Cash Flow | $-11,310 | $-8,550 | $N/A | $-4,973 | $-3,319 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -40 | N/A | -101 | -27 |
| Other Investing Activity | -320 | 0 | 0 | 500 | 2,856 |
| Investing Cash Flow | $-340 | $-40 | $N/A | $399 | $2,829 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 10,230 | 120 | 0 | 34,575 | 9,673 |
| Financing Cash Flow | $10,230 | $120 | $N/A | $34,575 | $9,673 |
| Exchange Rate Effect | 110 | 90 | N/A | 110 | 30 |
| Beginning Cash Position | 31,750 | 40,130 | N/A | 10,407 | 1,194 |
| End Cash Position | 30,440 | 31,750 | N/A | 40,517 | 10,407 |
| Net Cash Flow | $-1,300 | $-8,380 | $N/A | $30,111 | $9,213 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,310 | -8,550 | N/A | -4,973 | -3,319 |
| Free Cash Flow | -11,310 | -8,550 | 0 | -4,973 | -3,319 |